changes in autoimmune markers of the anti-cardiolipin syndrome on days of extreme geomamagnetic activity

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 17, Issue 4, 2006, Pages 269-278

  Stoupel, E ^a   Monselise, Y ^b   Lahav, J ^c  

^a Division of Cardiology   (Israel)

^b Laboratory of Clinical Immunology   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

anticardiolipin antibodies anti 2.glycoprotein antibodies; immunoglobulins; lupus anticoagulants

Indexed keywords

BIOLOGICAL MARKER; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PROTON; VIPER VENOM;

ARTICLE; AUTOIMMUNITY; BLOOD CLOTTING TIME; COSMIC RADIATION; ENVIRONMENTAL FACTOR; EPIDEMIC; IMMUNE SYSTEM; MAGNETISM; SOLAR ENERGY;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; ELECTROMAGNETIC FIELDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; SOLAR ACTIVITY;

EID: 33847126217     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2006.17.4.269     Document Type: Article

References (35)

1. Tchizevsky, AL. The terrestial echoes of solar storms. First ed. (1936); Second revised ed. (1976). Nauka.
2. Budai, A. Taches solaires et meningite cerebrospinale. Revue de Pathologie et d ’Hygiene general, 1931:419:aout.
3. Weichover, ST. Some functional characteristics of corinobacteria. Microbiol Epidemiol Immunol Moscow 1935; 15(6).
4. Stoupel, E, Joshua, H, Lahav, J. Human blood coagulation parameters and geomagnetic activity European J Int Med 1996; 7:217–220.
5. Stoupel, E, Shimshoni, M. Hospital cardiovascular deaths and total distribution of deaths in 180 co nsecutive months with different cosmic physical activity:a correlative study (1974-1988) Intern. J Biometeotol 1991; 35:6–9.
6. Stoupel, E, Shimshoni, M, Agmon, J. Is Localization of acute myocardial infarction time related? Clin Cardiol 1988; 11:45–49.
7. Stoupel, E, Domarkiene, S, Radishauskas, R, Abramson, E, Sulkes, J. Deaths from ischemic and hemorrhagic stroke on days with different levels of geomagnetic activity. Seminars Cardiol 2003; 9;2:46–51.
8. Stoupel, E, Domarkiene, S, Radishauskas, R, Abramson, E. Sudden cardiac death and geomagnetic activity: links to age, gender and agony time. J Basic Clin Physiol Pharmacol 2002; 13;1:11–22.
9. Stoupel, E. The effect of geomagnetic activity on cardiovascular parameters. Biomed Pharmacother 2002; 56: 247s–256s. (Editorial)
10. Stoupel, E, Abramson, E, Gabbay, U & Pick, AJ. Relationship between immunoglobulin level and the extremes of solar activity. Intern J Biometeorol 1995;38:89–91.
11. Zarifis, JH. Atherosclerosis, thrombosis, and inflammatory risk factors, from history and the laboratory to real life. Eur Heart J 2005; 26:317–318. (Editorial)
12. Geisler, T, Bhatt, D. The role of inflammation in atherothrombosis: current and future strategies in medical treatment. Med Sc Monit 2005; 10(12):RA308–316.
13. Matsuura, E, Kobayashi, K, Koike, K, Shoenfeld, Y. Autoantibody-mediated atherosclerosis Autoimmunity Rev 2002; 1:348–353.
14. Hughes, GR, Harris, EN, Gharavi, AE. The anticardiolipin syndrome. J Rheumatol 1986; 13:486–9.
15. Wilson, WA, Gharavi, AE, Koike, T, Lockshin, MD, Branch, DW, Piette, JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42:1309–11
16. Alarcon-Segovia, D, Deleze, M, Oria, CV, Sanchez-Guerrero, J, Gomez-Pacheco, L, Cabiedes, J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68:353–65.
17. Matsuura, E, Igarashi, Y, Fujimoto, M, Ichikawa, K, Koike, T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336:177–178.
18. Galli, M, Comfurius, P, Maassen, C, Hemker, HC, de Baets, MH, van Breda-Vriesman, PJ, et al (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990;335(8705):1544–7.
19. Meroni, PL, del Papa, N, Gambini, D, Tincani, A, Balestrieri, G. Antiphospholipid antibodies and endothelial cells. Lupus 1994;3:267–269
20. Bowie, EJ, Thompson, JH, Pascuzzi, CA, Owen, CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963;62:416–430
21. NOAA National Geophysical Data Center (Monthly) Geomagnetic Indices Bulletin Space Environment Center (Weekly). Preliminary Report and Forecast of Solar Geophysical Data. Boulder, Co. USA
22. Wilson, WA, Gharavi, AE, Koike, T, Lockshin, MD, Branch, DW, Piette, JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42(7):1309–11.
23. Galli, M,Comfurius, P, Maassen, C, et al. Anticardiolipin antibodies (ACA) directed not to Cardiolipin but to plasma protein cofactor. Lancet 1990; 335:1544–7.
24. McNeil, HP, Simpson, RJ, Chesterman, CN, Krilis, SA. Anti Phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120–4.
25. Hunt, JE, McNeil, HP, Morgan, GJ, Crameri, Gl, RM, Crameri, RM, Krilis, SA. Aphospholipid-: β2-glycoprotein I complex is an antigen for anticardiolipin 26 antibodies occurring in autoimmune disease but not with infection. Lupus 1992 1: 75–81.
26. Arvieux, J, Roussel, B, Jacob, MC, Colomb, MG. Measurement of antiphospholipid antibodies by Elisa using ß2-glycoprotein I as an antigen. J Immunol Methods 1991,143: 223–9.
27. Tsutsumi, A, Matsuura, E, Ichikawa, K, Fujisaku, A, Mukai, M, Kobayashi, S, Koike, T. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996,39:1466–1474.
28. 2-29 glycoprotein I is potentiated by a distinct sub group of anticardiolopin antibodies. Thromb Haemost 1992;68:297–300.
29. Viard, JP, Amoura, Z, Bach, JE. Association of anti β2-glycoprotein I with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992,93:181–6.
30. Bevers, EM, Galli, M, Barbui, T, Comfurius, P, Zwaal, RF. Lupus anti coagulant IgGs (La) are not directed to phospholipd only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:629–32.
31. Woodruff, E, Antiphospholipid antitibodies: New complexities and new assays. Arthritis Rheum 1996, 39:1441–3.
32. Tsutsumi, A, Matsuura, E, Ichikawa, K, Fujisaku, A, Mukai, M, Koike, T. IgA class anti-beta2-gIycoprotein 1 in patients with systemic lupus erythematosus. J Rheumatol. 1998;25(1):74–8.
33. Harris, EN, Pierangeli, SS. Equivocal anti phospholipid syndrome. JAI 2000 15:81–8.
34. Galli, M, Barbui, T. Prothrombin as cofactor for antiphospholipids. Lupus 1998;7 (suppl 2):S37–S40.
35. Stoupel, E, Abramson, E, Israelevich, P, Sulkes, J, Harell, D. C-reactive protein serum level and cosmophysical activity. Fourth International Meeting Intensive Cardiac Care. September 27-29, 2005, Tel Aviv. Eur Heart J (in press).